ΑΜΕΡΙΚΑΝΟΙ ΕΡΕΥΝΗΤΕΣ ΕΠΙΒΕΒΑΙΩΝΟΥΝ ΤΗΝ ΘΕΡΑΠΕΙΑ ΚΑΡΚΙΝΟΥ ΜΕ ΒΙΟΣΥΝΤΟΝΙΣΜΟ!
Οι Αμερικανοί "ανακαλύπτουν" πάλι την Αμερική, κατά το κοινώς λεγόμενο! 80 χρόνια μετά την ανακάλυψη από τον Αμερικανό Ρ. Ράϊφ της καταστροφής καρκινικών κυττάρων με την εφαρμογή βιοσυντονισμού, που άνοιξε τον δρόμο για την συγκεκριμμένη θεραπευτική μέθοδο και είχε σαν αποτέλεσμα, δυστυχώς, να εξοντωθεί ο ίδιος από τα πανίσχυρα (από τότε!) οικονομικά συμφέροντα στον χώρο της υγείας, Αμερικανοί ερευνητές έρχονται σήμερα να τον επιβεβαιώσουν! Αλλά (ευτυχώς για εμάς) τους έχουν προλάβει οι Ρώσοι, που μας έχουν εφοδιάσει, ήδη, εδώ και λίγα χρόνια, με εύχρηστες φορητές συσκευές θεραπείας με βιοσυντονισμό, εφοδιασμένες μάλιστα με χιλιάδες ειδικά προγράμματα (φορητές συσκευές βιοσυντονισμού BIOMEDIS). Στις σχετικές δημοσιεύσεις που είδαν το φως της δημοσιότητας αναφέρεται ότι δοκιμάστηκε η εφαρμογή ηλεκτρομαγνητικών πεδίων διαφόρων συχνοτήτων σε πάσχοντες από διάφορες μορφές καρκίνου, με μεγάλη επιτυχία σαν αποτέλεσμα και με συνέπεια στις πλείστες των περιπτώσεων οι ασθενείς να αποφύγουν τις εξαιρετικά βλαπτικές σχετικές θεραπείες που εφαρμόζονται συνήθως.
Δείτε τις σχετικές δημοσιεύσεις παρακάτω:
Br J Cancer. 2011 Aug 23;105(5):640-8. doi: 10.1038/bjc.2011.292. Epub 2011 Aug 9.
Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields.
Costa FP1, de Oliveira AC, Meirelles R, Machado MC, Zanesco T, Surjan R, Chammas MC, de Souza Rocha M, Morgan D, Cantor A, Zimmerman J, Brezovich I, Kuster N, Barbault A, Pasche B.
Abstract
BACKGROUND:
Therapeutic options for patients with advanced hepatocellular carcinoma (HCC) are limited. There is emerging evidence that the growth of cancer cells may be altered by very low levels of electromagnetic fields modulated at specific frequencies.
METHODS:
A single-group, open-label, phase I/II study was performed to assess the safety and effectiveness of the intrabuccal administration of very low levels of electromagnetic fields amplitude modulated at HCC-specific frequencies in 41 patients with advanced HCC and limited therapeutic options. Three-daily 60-min outpatient treatments were administered until disease progression or death. Imaging studies were performed every 8 weeks. The primary efficacy end point was progression-free survival 6 months. Secondary efficacy end points were progression-free survival and overall survival.
RESULTS:
Treatment was well tolerated and there were no NCI grade 2, 3 or 4 toxicities. In all, 14 patients (34.1%) had stable disease for more than 6 months. Median progression-free survival was 4.4 months (95% CI 2.1-5.3) and median overall survival was 6.7 months (95% CI 3.0-10.2). There were three partial and one near complete responses.
CONCLUSION:
Treatment with intrabuccally administered amplitude-modulated electromagnetic fields is safe, well tolerated, and shows evidence of antitumour effects in patients with advanced HCC.
Purpose
Because in vitro studies suggest that low levels of electromagnetic fields may modify cancer cell growth, we hypothesized that systemic delivery of a combination of tumor-specific frequencies may have a therapeutic effect. We undertook this study to identify tumor-specific frequencies and test the feasibility of administering such frequencies to patients with advanced cancer.
Patients and methods
We examined patients with various types of cancer using a noninvasive biofeedback method to identify tumor-specific frequencies. We offered compassionate treatment to some patients with advanced cancer and limited therapeutic options.
Results
We examined a total of 163 patients with a diagnosis of cancer and identified a total of 1524 frequencies ranging from 0.1 Hz to 114 kHz. Most frequencies (57–92%) were specific for a single tumor type. Compassionate treatment with tumor-specific frequencies was offered to 28 patients. Three patients experienced grade 1 fatigue during or immediately after treatment. There were no NCI grade 2, 3 or 4 toxicities. Thirteen patients were evaluable for response. One patient with hormone-refractory breast cancer metastatic to the adrenal gland and bones had a complete response lasting 11 months. One patient with hormone-refractory breast cancer metastatic to liver and bones had a partial response lasting 13.5 months. Four patients had stable disease lasting for +34.1 months (thyroid cancer metastatic to lung), 5.1 months (non-small cell lung cancer), 4.1 months (pancreatic cancer metastatic to liver) and 4.0 months (leiomyosarcoma metastatic to liver).Conclusion
Cancer-related frequencies appear to be tumor-specific and treatment with tumor-specific frequencies is feasible, well tolerated and may have biological efficacy in patients with advanced cancer.
Anna Hunt, Staff
An important breakthrough may prevent people from suffering from cancer or the aggressive radiation and chemotherapy treatments used to kill cancer cells.
Anthony Holland, an Associate Professor and Director of Music Technology at Skidmore College in New York, U.S., and his fellow researchers discovered that, by creating custom digital electronic signals, they can destroy cancer cells and Methicillin-resistant Staphylococcus aureus (MSRA). In their laboratory experiments, the team used Oscillating Pulsed Electric Fields (OPEF) to induce sympathetic resonant vibrations which in a short amount of time shattered targeted cells from pancreatic cancer, leukemia, ovarian cancer, and the dangerous antibiotic-resistant bacterium MSRA. Below is an image showing the effect that the resonant frequencies had on leukemia cells.
Just as various sound frequencies can shatter different types of crystal and glass, shattering microscopic organisms is possible because they have many similar properties of liquid crystals.
Holland created a device that uses pulsating plasma lights to emit the right frequency electronic signals to induce sympathetic resonant vibration in targeted microorganisms. Holland’s research showed that not only can one change the vibration of a biological living microorganism with an electronic signal, but also that different frequencies of this electronic signal can be used to target different types of microorganisms.
Below is a TED talk by Anthony Holland during which he reveals his discoveries. Starting midway through his talk, Holland shows stunning videos of how various cancer cells react to eleventh harmonic frequency combinations. It took the researchers over 15 months of trying hundreds of frequency combinations to find the ones with the potential to kill cancer cells. Holland’s goal is to create a treatment that can be used to shatter cancer cells and heal cancer patients painlessly and without toxic methods.
Δείτε παρακάτω και το σχετικό βίντεο:
Για οποιαδήποτε πρόσθετη πληροφορία και οποιαδήποτε απορία καλεστε στο
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου